Phase 1 Study of MGD007 in Relapsed/Refractory Metastatic Colorectal Carcinoma
NCT02248805
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
95
Enrollment
INDUSTRY
Sponsor class
Conditions
Colorectal Carcinoma
Interventions
DRUG:
MGD007
Sponsor
MacroGenics